Calithera Biosciences Inc.

CALA
$0.00 (+ $0.00 + 0.00%)
Last updated: 2026-07-04 02:16 UTC
CALA Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorFinancial Services
IndustryShell Companies
ISINUS13089P5070
CUSIP13089P507
Market Price0.0
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPSN/A
Market Cap$974
Book Value-0.4
Price to Book-0.0
Beta1.0
52w High0.0
52w Low0.0
Next Earnings DateN/A

Calithera Biosciences Inc. trades under ticker CALA on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Financial Services exposure. Identifiers: ISIN US13089P5070, CUSIP 13089P507.

About the Company
Calithera Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule compounds, primarily in the field of tumor biology. Its primary function involves discovering and advancing therapeutic candidates that can potentially address various cancer-related challenges. The company operates within the biotechnology sector, specifically targeting precision oncology. Although it has transitioned into a plan of liquidation, historically, Calithera Biosciences Inc. contributed to advancements in cancer treatment through innovative small molecule therapies. Headquartered in South San Francisco, California, the company was founded in 2010 and played a role in shaping the landscape of cancer research.
Price History